🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Mississippi › Hattiesburg

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Hattiesburg, MS

Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Hattiesburg. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 3
  • Hattiesburg Clinic /ID# 248033, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04928846

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nagre-recruitPhase 2
  • Local Institution - 0180, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07680764

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Nagre-recruitPhase 3
  • Hattiesburg Clinic Hematology/Oncology ( Site 0104), Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06170788

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • Hattiesburg Clinic Hematology/Oncology, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Nagre-recruitPhase 3
  • Research Site, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06357533

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Nagre-recruitPhase 3
  • Hattiesburg Clinic Hematology/Oncology, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06561386

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Nagre-recruitPhase 3
  • Clinical Study Site, Hattiesburg
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06767514

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral
  • Massive Bio SYNERGY-AI site, Hattiesburg
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa Hattiesburg

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.